Metallointercalator [Ru(dppz)2(PIP)]2+ renders BRCA wild-type triple-negative breast cancer cells hypersensitive to PARP inhibition
There is a need to improve and extend the use of clinically approved poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi), including for BRCA wild-type triple-negative breast cancer (TNBC). The demonstration that ruthenium(II) polypyridyl complex (RPC) metallointercalators can rapidly stall DNA rep...
        Salvato in:
      
    
                  | Autori principali: | , , , , , , , | 
|---|---|
| Natura: | Articolo | 
| Lingua: | English | 
| Pubblicazione: | 
        American Chemical Society
    
      2020
     | 
| Accesso online: | http://psasir.upm.edu.my/id/eprint/86732/1/Metallointercalator.pdf | 
| Tags: | 
       Aggiungi Tag    
     
      Nessun Tag, puoi essere il primo ad aggiungerne! !
    | 
